Bridgeway Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-1,650
| Closed | -$858K | – | 1229 |
|
2024
Q3 | $858K | Sell |
1,650
-200
| -11% | -$104K | 0.02% | 728 |
|
2024
Q2 | $1M | Sell |
1,850
-5,250
| -74% | -$2.84M | 0.02% | 682 |
|
2024
Q1 | $3.68M | Hold |
7,100
| – | – | 0.08% | 381 |
|
2023
Q4 | $3.35M | Buy |
+7,100
| New | +$3.35M | 0.07% | 421 |
|
2020
Q4 | – | Sell |
-75,425
| Closed | -$20.3M | – | 1320 |
|
2020
Q3 | $20.3M | Sell |
75,425
-35,400
| -32% | -$9.51M | 0.46% | 61 |
|
2020
Q2 | $29.1M | Sell |
110,825
-18,625
| -14% | -$4.9M | 0.59% | 45 |
|
2020
Q1 | $29.4M | Sell |
129,450
-43,550
| -25% | -$9.89M | 0.67% | 39 |
|
2019
Q4 | $52.3M | Buy |
+173,000
| New | +$52.3M | 0.7% | 30 |
|
2018
Q1 | – | Sell |
-278,100
| Closed | -$62.6M | – | 1394 |
|
2017
Q4 | $62.6M | Buy |
278,100
+6,700
| +2% | +$1.51M | 0.67% | 35 |
|
2017
Q3 | $51.5M | Buy |
271,400
+36,500
| +16% | +$6.93M | 0.59% | 50 |
|
2017
Q2 | $44.2M | Buy |
234,900
+12,400
| +6% | +$2.33M | 0.53% | 69 |
|
2017
Q1 | $36.8M | Buy |
+222,500
| New | +$36.8M | 0.45% | 79 |
|
2016
Q1 | – | Sell |
-149,756
| Closed | -$20.9M | – | 1447 |
|
2015
Q4 | $20.9M | Buy |
149,756
+1,150
| +0.8% | +$160K | 0.39% | 78 |
|
2015
Q3 | $20.8M | Hold |
148,606
| – | – | 0.44% | 50 |
|
2015
Q2 | $24.4M | Buy |
148,606
+5,296
| +4% | +$869K | 0.48% | 32 |
|
2015
Q1 | $22.1M | Buy |
143,310
+37,800
| +36% | +$5.84M | 0.46% | 37 |
|
2014
Q4 | $13.3M | Hold |
105,510
| – | – | 0.3% | 72 |
|
2014
Q3 | $12.6M | Buy |
105,510
+17,600
| +20% | +$2.11M | 0.32% | 56 |
|
2014
Q2 | $9.46M | Buy |
87,910
+24,400
| +38% | +$2.63M | 0.25% | 69 |
|
2014
Q1 | $6.32M | Buy |
63,510
+10,500
| +20% | +$1.05M | 0.18% | 111 |
|
2013
Q4 | $4.9M | Buy |
53,010
+9,300
| +21% | +$859K | 0.15% | 134 |
|
2013
Q3 | $3.66M | Buy |
43,710
+35,210
| +414% | +$2.94M | 0.12% | 161 |
|
2013
Q2 | $696K | Buy |
+8,500
| New | +$696K | 0.03% | 793 |
|